Oncology;ONKOLOGIE

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 10, 1997, Pages 1161-1165

  Osieka, Rainhardt ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Antineoplastic chemotherapy; Immunotherapy; Oncology

Indexed keywords

ACROLEIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYTOKINE; GROWTH FACTOR; MESNA; METHOTREXATE; MITOMYCIN; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RESEARCH; CANCER THERAPY; CONFERENCE PAPER; DRUG ACTIVITY; DRUG DEVELOPMENT; DRUG RESISTANCE; HUMAN; MOLECULAR BIOLOGY; PALLIATIVE THERAPY; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; HISTORY, 20TH CENTURY; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL;

EID: 0030981690     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Bailar III, J. C., Gornik, H. L., N. Engl. J. Med. 336, 1569 (1997)
2. Weatherall, D., Science And The Quiet Art, Medical Research & Patient Care, Oxford University Press. Oxford-To- kyo etc. (1995)
3. Bertino, J. R., J. Clin. Oncol. 11, 5 (1993)
4. Kohn, K. W., J. Natl. Cancer Inst. 88, 1255 (1996)
5. Bishop, J. M., Cell 64, 235 (1991)
6. McGahon, A., Bissonette, R., Schmitt, M. et al., Blood 83, 1179 (1994)
7. Osieka, R., Seeber, S., Bruntsch, U. et al., Dtsch. med. Wschr. 99, 2468 (1974)
8. Peyrone, M., Anal. d. Chemie u. Pharm. LI Bds., I Heft, 1-29 (1844)
9. Osieka, R., Schmidt, C. G., Klin. Wschr. 57, 1249 (1979)
10. Boyd, M. R., Paull, K. D., Drug Dev. Res. 34, 91 (1995)
11. Brock, N., Pohl, J., Stekar, J. et al., Eur. J. Cancer Clin. Oncol. 18, 1377 (1982)
12. Schuchter, L. M., Luginbuhl, W. E., Meropol N. J., Semin. Oncol. 19, 742 (1992)
13. Hoelzer, D., N. Engl. J. Med. 336, 1822 (1997)
14. Schabel, F. M., Cancer Res. 29, 2384 (1969)
15. Opelz, G., Schwarz, V., Grayson, H. et al., Multicenter analysis of posttransplant malignancies. In J. L. Touraine et al. (eds.). Cancer in Transplantation. Prevention and Treatment, pp. 17-23, Kluwer Acad. Publ., The Netherlands (1996)
16. Gale, R. P., Simone, J. V., Hoelzer, D., F. E., Leukemia 5, 632 (1991)
17. Li, M. C., Hertz, R., Spencer, D. B., Proc. Soc. Exp. Biol. Med. 93, 361 (1956)
18. Bonadonna, G., Valagussa, P., Moliterni, B. S. et al., N. Engl. J. Med. 332, 901 (1995)
19. De Conno, F., Caraceni, A., Groff, L. et al., Eur. J. Cancer 32 A, 1142 (1996)
20. Berenson, J. R., Lichtenstein, A., Porter, L. et al., N. Engl. J. Med. 334, 488 (1996)
21. Wissenschaftlicher Beirat der Bundesärztekammer unter Mitwirkung des Paul-Ehrlich-Instituts, Dt. Ärztbl. 94, 1268 (1997)
22. Loft, S., Poulsen, H. E., J. Mol. Med. 74, 297 (1996)
23. Lowe, S. W. Ruley, H. E., Jacks, T. et al., Cell 74, 957 (1993)
24. Grunicke, H., Hoffmann, J., Utz, I., Ü. F., Ann. Hematol. 69, S1 (1994)
25. Raderer, M., Scheithauer, W., Cancer 72, 3553 (1993)
26. Connors, T. A., Ann. Oncol. 7, 445 (1996)
27. Takahara, P. M. et al., Nature 377, 649 (1995)
28. Ledley, F. D., Hum. Gene Ther. 7, 1193 (1996)
29. Riethmüller, G., Schneider-Gädicke, E., Schlimok, G. et al., Lancet 343, 1177 (1994)
30. Degos, L., Dombret, H., Chomienne, C. et al., Blood 85, 2643 (1995)
31. Thun, M. J., Namboodiri, M. M., Heath, C. W., New Engl. J. Med. 325, 1593 (1991)
32. Chang, M. H., Chen, C. J., Lai, M. S. et al., N. Engl. J. Med. 336, 1855 (1997)